Boca Raton, FL, United States of America

Ross Dixon

This inventor holds 1 USPTO granted patent. Top assignee: Ivax Laboratories, Inc.. Active years: 1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ross Dixon. Retrieved from https://idiyas.com/inventor/ross-dixon-btc3ecfn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ross Dixon

Introduction

Ross Dixon is an accomplished inventor based in Boca Raton, FL. He has made significant contributions to the field of pharmaceuticals, particularly in the development of opioid antagonists. His innovative approach has led to advancements that aim to improve patient outcomes while minimizing side effects.

Latest Patents

One of Ross Dixon's notable patents is focused on glucuronic acid derivatives of opioid antagonists. This patent describes a method for intestine-specific delivery of an opioid antagonist, which can be achieved without substantial central nervous system effects. By administering the antagonist orally in the form of the glucuronide derivative, the potential for adverse effects is significantly reduced. This patent highlights his commitment to enhancing drug delivery systems.

Career Highlights

Ross Dixon is currently associated with Ivax Laboratories, Inc., where he continues to work on innovative pharmaceutical solutions. His career has been marked by a dedication to research and development, leading to the creation of effective medications that address critical health issues.

Collaborations

Throughout his career, Ross has collaborated with esteemed colleagues such as Ronald R. Tuttle and Maciej M. Smulkowski. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further driving innovation in their field.

Conclusion

In summary, Ross Dixon is a prominent inventor whose work in opioid antagonists has the potential to transform pharmaceutical practices. His innovative patent and collaborations reflect his dedication to improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…